Novel Anticoagulant Candidates
Thrombosis
Key Facts
Indication
Thrombosis
Phase
Preclinical
Status
Research
About Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Hebei Changshan Biochemical Pharmaceutical's mission is to be a global leader in the development and supply of high-quality, life-saving anticoagulant therapies. Its core achievement is establishing itself as a vertically integrated powerhouse in the heparin value chain, from sourcing to finished dosage forms, serving consistent global demand. The company's strategy focuses on leveraging its proprietary biochemical processing platform to maintain cost and quality leadership, while expanding its portfolio of low molecular weight heparin (LMWH) products and exploring novel antithrombotic candidates. Its significant market valuation reflects its entrenched position in this essential therapeutic area.
View full company profileTherapeutic Areas
Other Thrombosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Tarysol | Ablatotech | Phase 1 |